Previous 10 | Next 10 |
TEGNA Inc. (NYSE: TGNA) will host a conference call to discuss its second quarter 2023 earnings results on Thursday, August 3, 2023, at 10:00 a.m. (ET). The conference call will be webcast through the company’s website , and is open to investors, the financial community, the media ...
2023-06-25 10:02:00 ET Television usage continued a seasonal decline in May -- and it also declined year-over-year, while streaming continued to gain share against other uses that also saw drops in time spent. Overall TV consumption fell for the fourth straight month, down 4.4% ...
RYE, N. Y., June 07, 2023 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 15 th Annual Media & Entertainment Symposium at the Harvard Club in New York City on Thursday, June 8, 2023. The symposium will feature discussions with leading companies and organizations across the media ecosystem...
New immunological data assessed by tetramer staining confirms the induction of T cell responses in treated patients All trial patients treated with TG4050 monotherapy continue to remain in remission to date Transgene and NEC are preparing a Phase II trial to further demonstrate the potent...
TG4001 can induce de novo immune responses against HPV16 antigens E6 and E7 in patients with advanced HPV16-positive anogenital cancers Patients with complete objective response showed strong vaccine-induced immunoreactivity Transgene is preparing for a potentially registrational stud...
2023-06-02 07:46:26 ET TEGNA ( NYSE: TGNA ) enters into an accelerated share repurchase agreement with JPMorgan Chase Bank and a 20% increase to its regular quarterly dividend. Under the agreement, TEGNA will repurchase $300M in shares from JPMorgan, with an initial d...
Receives 8,640,452 TEGNA shares from Standard General in satisfaction of $136 million termination fee TEGNA Inc. (NYSE: TGNA) today announced that it has entered into an accelerated share repurchase agreement (“ASR”) with JPMorgan Chase Bank, National Association (ȁ...
Presentations include new data further demonstrating the immune responses induced by TG4001 and recently updated results from the adjuvant Phase I trial of neoantigen vaccine TG4050 in head and neck cancer Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that desi...
2023-05-25 16:50:40 ET Standard General said it agreed to pay a termination fee over its failed Tegna ( NYSE: TGNA ) acquisition in Tegna shares. Standard General on Wednesday entered into an agreement where it will transfer Tegna ( TGNA ) shares valued at the $136 million...
TEGNA Inc. (NYSE: TGNA) today announced its stations received 84 Regional Edward R. Murrow Awards. KARE in Minneapolis received 12 individual awards, the most given this year, and the most in its history. Three stations – KARE, KGW and WFAA – garnered the overall excellence hono...
News, Short Squeeze, Breakout and More Instantly...
Strasbourg, France, and Lund, Sweden, July 22, 2024, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stock...
Gray Media stations in Anchorage and Juneau will broadcast all locally available Seattle Kraken games, free over-the-air beginning with the 2024-2025 season TEGNA Inc. (NYSE: TGNA), the Seattle Kraken and Gray Media (NYSE: GTN) today announced that Gray’s KAUU in Anchorage and ...
NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Olaplex Holdings, Inc. (NASDAQ: OLPX) (“OLAPLEX” or “the Company”) today announced the appointment of two highly seasoned leaders to its executive team. Catherine Dunleavy will join OLAPLEX as Chief Operating Officer and Chie...